Diabetes & Antenatal Milk Expressing (Dame): A Randomised Controlled Trial Diabetes and Antenatal Milk Expressing (Dame) a Randomised Controlled Trial

Grant number: 1005345 | Funding period: 2011 - 2014

Completed

Abstract

Infants of women with diabetes in pregnancy have an increased risk of low blood sugar and other complications after birth and of developing diabetes and being obese later in life. Many maternity providers encourage these women to express breast milk before birth to have it available if the infant needs supplementary feeding. Evidence for this practice is lacking so we are planning the first study exploring the safety and effectiveness of antenatal expression of breast milk in late pregnancy for women with diabetes in pregnancy.

Related publications (3)

Safety and efficacy of antenatal milk expressing for women with diabetes in pregnancy: Protocol for a randomised controlled trial

DA Forster, S Jacobs, LH Amir, P Davis, SP Walker, K McEgan, G Opie, SM Donath, AM Moorhead, R Ford, C McNamara, A Aylward, L Gold

2014-01-01

Introduction: Many maternity providers recommend that women with diabetes in pregnancy express and store breast milk in late pregn..

Continuous positive airway pressure failure in preterm infants: Incidence, predictors and consequences

PA Dargaville, A Aiyappan, AG De Paoli, RGB Dalton, CA Kuschel, CO Kamlin, F Orsini, JB Carlin, PG Davis

2013-07-01

Background: Preterm infants ≤32 weeks' gestation are increasingly being managed on continuous positive airway pressure (CPAP), wit..

Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure.

PA Dargaville, A Aiyappan, AG De Paoli, CA Kuschel, COF Kamlin, JB Carlin, PG Davis

2013-01-01

To evaluate the applicability and potential effectiveness of a technique of minimally-invasive surfactant therapy (MIST) in preter..

University of Melbourne Researchers

Susan Walker